INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)
Amla (Emblica officinalis) and haldi (Curcuma longa) are combined to form "Nishamalaki" or "Nisha Amalaki," which is used to cure diabetes. It works well for diabetes-related neuropathy and urinary problems in addition to diabetes itself. One of the most important health issues facing the world today is diabetes mellitus. The population of diabetic Indians has been shown to have poor glycemic control. All health agencies have identified diabetes as one of four priority non-communicable diseases for prevention and control. The goal of the current report is to examine the potential uses of an effective herbal combination of amla and haldi as a sustained release tablet for Type 2 Diabetes mellitus prevention and health promotion.
Keywords:
Nishamalaki, diabetes mellitus, amla, haldi.
Cite Article:
"To Study Nishamalaki sustained Release Tablet as an antidiabetic", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.8, Issue 1, page no.a103-a104, January-2023, Available :http://www.ijnrd.org/papers/IJNRD2301115.pdf
Downloads:
000118755
ISSN:
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Facebook Twitter Instagram LinkedIn